Over $1.3 million of neurological research funding
Over $1.3 million of neurological research funding in July round
The Neurological Foundation is pleased to
announce that over $1.3 million of research funding has been
allocated in its July grant round.
The July grants allocated include the funding of the following projects which will be carried out at the University of Auckland, the University of Otago Christchurch and the University of Otago:
- Epilepsy: A proof-of-principle
study of a tailor-made, intranasal anti-convulsant drug
carrier system
- Fragile X Syndrome: Developing
an authentic research model of Fragile X Syndrome using an
innovative New Zealand-developed technology
-
Multiple sclerosis: Can a new drug-delivery system
specifically target lesions in a model of multiple sclerosis
to improve brain function?
- Parkinson’s
disease: Investigating the role of sub-thalamic nucleus
activity in impulsivity in a model using optogenetic
technology
- Alzheimer’s disease: The
investigation of a neuroprotective protein’s potential to
rescue memory function
- Epilepsy: A laboratory
based study to determine reliable methods for examining the
effect of cannabidiol in epilepsy
- Brain
function: Investigating the mechanisms of proteins in
oxidative stress in brain disorders
- Stroke:
Investigating a new approach to brain stimulation in a model
of stroke to optimise recovery
- Traumatic brain
injury: Development of a skin/skull/brain model to measure
impact forces to the head and brain-injury mechanisms
-
Schizophrenia and ADHD-like hyperactivity: Measuring changes
in brain circuitry to increase knowledge of the anatomical
basis of schizophrenia and ADHD-like hyperactivity
All lead investigator details are included in the attached, along with summaries of each grant.
ends